STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

Annexon to Present at the BofA Securities 2021 Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Annexon, Inc. (Nasdaq: ANNX) announced its participation in the Bank of America Securities 2021 Virtual Healthcare Conference on May 12, 2021, at 11:45 am EDT. Douglas Love, President & CEO, will present live at the event. Investors can access the live webcast through the ‘Events & Presentations’ section on Annexon's website, and a replay will be available for 30 days post-event. The company is focused on developing novel therapies for classical complement-mediated autoimmune and neurodegenerative disorders, utilizing a biomarker-driven strategy to enhance treatment efficacy.

Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Today Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated autoimmune and neurodegenerative disorders of the body, brain and eye, announced that Douglas Love, Esq., President & Chief Executive Officer, will present at the Bank of America Securities 2021 Virtual Healthcare Conference on May 12, 2021 at 11:45 am EDT.

A live webcast of the event can be accessed under the ‘Events & Presentations’ section on the Investors page at www.annexonbio.com.   A replay of the webcast will be archived on the Annexon website for 30 days following the presentation.

About Annexon, Inc.

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is deploying a disciplined, biomarker-driven development strategy designed to select indications, identify patients and measure target engagement and response to treatment. For more information, visit www.annexonbio.com.


FAQ

When is Annexon presenting at the Bank of America Securities Healthcare Conference?

Annexon is presenting on May 12, 2021, at 11:45 am EDT.

Where can I watch Annexon's presentation at the healthcare conference?

You can watch the presentation live on Annexon's website under the ‘Events & Presentations’ section.

How long will the webcast replay of Annexon's presentation be available?

The replay will be available for 30 days following the presentation.

What is the focus of Annexon, Inc.'s pipeline?

Annexon develops therapies for classical complement-mediated autoimmune and neurodegenerative disorders.

What is the stock symbol for Annexon, Inc.?

The stock symbol for Annexon, Inc. is ANNX.

Annexon, Inc.

NASDAQ:ANNX

ANNX Rankings

ANNX Latest News

ANNX Stock Data

561.75M
98.66M
0.5%
106.1%
7.35%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BRISBANE